These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28870177)

  • 21. A randomized double blind, placebo controlled trial of topical Tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis.
    Cibere J; Deng Z; Lin Y; Ou R; He Y; Wang Z; Thorne A; Lehman AJ; Tsang IK; Esdaile JM
    J Rheumatol; 2003 Mar; 30(3):465-7. PubMed ID: 12610802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis.
    Wang HL; Jiang Q; Feng XH; Zhang HD; Ge L; Luo CG; Gong X; Li B
    BMC Complement Altern Med; 2016 Jul; 16():215. PubMed ID: 27411429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chinese herbal medicine Xinfeng Capsule in treatment of rheumatoid arthritis: study protocol of a multicenter randomized controlled trial.
    Liu J; Huang CB; Wang Y; Xu GQ; Cheng YY; Feng YX; Liu L; Qi YJ
    J Integr Med; 2013 Nov; 11(6):428-34. PubMed ID: 24299607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tripterygium wilfordii: An inspiring resource for rheumatoid arthritis treatment.
    Zhang Y; Mao X; Li W; Chen W; Wang X; Ma Z; Lin N
    Med Res Rev; 2021 May; 41(3):1337-1374. PubMed ID: 33296090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Etanercept combined with Tripterygium wilfordii polyglycoside for treatment of rheumatoid arthritis in the elderly: a clinical study].
    He WZ; Yin ZH; Gao JH; Ye ZZ; Xie Y; Kong WH; Chen YS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Mar; 34(3):267-71. PubMed ID: 24758073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of tripterygium wilfordii Hook F plus TNF inhibitor for active rheumatoid arthritis: A multicentre, randomized, double-blind, triple-dummy controlled trial.
    Zhang X; Yang H; Zuo X; Wu L; Peng J; Li Z; Li H; Ji W; Zhang L; Li X; Dai L; Lu L; Yang N; Wei W; Shuai Z; Jiang Y; Liu Y; Lipsky PE; Chen H;
    Clin Immunol; 2023 Oct; 255():109749. PubMed ID: 37657525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the therapeutic efficacy of the Chinese herbal medicine Yishen Tongbi decoction in patients with active rheumatoid arthritis: protocol for a randomized, controlled, noninferiority trial.
    Zhao L; Li M; Xu Y; Liu L; Zhang M; Chen G
    Trials; 2019 Dec; 20(1):801. PubMed ID: 31888728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of the herbal medicine geonchildan for patients with active rheumatoid arthritis: study protocol for a randomized, double-blind, placebo-controlled, parallel pilot trial.
    Lee S; Cho Y; Kim J; Kang JW; Yoon GY; Lee JH; Jung SY; Kwon O; Shin KM; Lee JD
    Trials; 2018 Sep; 19(1):471. PubMed ID: 30176923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Chinese herb Tripterygium wilfordii Hook F for the treatment of systemic sclerosis-associated interstitial lung disease: data from a Chinese EUSTAR Center.
    Yang L; Wang Q; Hou Y; Zhao J; Li M; Xu D; Zeng X
    Clin Rheumatol; 2020 Mar; 39(3):813-821. PubMed ID: 31713733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy.
    Li Z; Zhang F; Kay J; Fei K; Han C; Zhuang Y; Wu Z; Hsia EC
    Int J Rheum Dis; 2016 Nov; 19(11):1143-1156. PubMed ID: 26259617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herbal therapy for treating rheumatoid arthritis.
    Cameron M; Gagnier JJ; Chrubasik S
    Cochrane Database Syst Rev; 2011 Feb; (2):CD002948. PubMed ID: 21328257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of the traditional Chinese medicine Juanbi pill combined with methotrexate in active rheumatoid arthritis: study protocol for a randomized controlled trial.
    Wang Q; Wang YR; Jia QY; Liu L; Xu CQ; Wang XY; Yao M; Cui XJ; Shi Q; Wang YJ; Liang QQ
    Trials; 2018 Mar; 19(1):188. PubMed ID: 29558967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Observation of the curative effect of Guizhi-Shaoyao-Zhimu decoction combined with methotrexate in the treatment of early rheumatoid arthritis based on ultrasonic evaluation: study protocol of a randomized, double-blind, controlled clinical trial.
    Shen J; Chen Q; Yang G; He Y
    Trials; 2021 Nov; 22(1):764. PubMed ID: 34732237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Huangqi Guizhi Wuwutang granule in patients with rheumatoid arthritis.
    Wang Y; Liu Y; Xi Z; Yu Y; Liu L; Mao J; Xiao L; Gu X; Yao M; Cui X; Shi Q; Wang Y; Liang Q
    Medicine (Baltimore); 2019 Mar; 98(11):e14888. PubMed ID: 30882703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of TCMs with anti-inflammatory effect in patients with rheumatoid arthritis: A network meta-analysis.
    Fang J; Liu M; Huang Z; Ma Y; Wang Y; Zheng X; Lv L; Liu C; Li W; Zhu Z; Zhu H; Hu J; Wang Y; Wang H
    Front Immunol; 2023; 14():1114930. PubMed ID: 36969172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, and placebo-controlled multicenter clinical trial of a novel cytotoxic T-lymphocyte antigen-4 fusion protein, Leining, in Chinese active rheumatoid arthritis patients with an inadequate response to methotrexate.
    Fan W; Zhao DB; Hu SX; Xu HJ; Zhang X; Zhang MJ; Chen ZW; Zhang FX; Zhu P; Li XF; Bi LQ; Zhou B; Bao CD
    Rheumatol Int; 2014 Nov; 34(11):1519-27. PubMed ID: 24671501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.
    Aletaha D; Bingham CO; Tanaka Y; Agarwal P; Kurrasch R; Tak PP; Popik S
    Lancet; 2017 Mar; 389(10075):1206-1217. PubMed ID: 28215362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoregulatory effects of Tripterygium wilfordii Hook F and its extracts in clinical practice.
    Luo D; Zuo Z; Zhao H; Tan Y; Xiao C
    Front Med; 2019 Oct; 13(5):556-563. PubMed ID: 30604167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical practice guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in treatment of rheumatoid arthritis].
    Na L; Quan J; Wei L; Jian L; Qing-Chun H; Kuan-Yu WU; Sheng-Hao TU; Zu-Shan Z; Wei-Heng C; Xiao-Xia LI; Yan-Qiong Z
    Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4149-4153. PubMed ID: 33164399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tripterygium wilfordii Hook F. in the treatment of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a clinical trial.
    Wang L; Gong L; Zhang X; Cao Y; Long P; Zhang W; Zeng X; Li C
    Clin Rheumatol; 2021 Jun; 40(6):2427-2438. PubMed ID: 33389313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.